LOXO
Loxo Oncology, Inc
LOXO
LOXO
Delisted
LOXO was delisted on the 14th of February, 2019.
158 hedge funds and large institutions have $3.61B invested in Loxo Oncology, Inc in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 48 increasing their positions, 55 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
13% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 55
52% less call options, than puts
Call options by funds: $16.8M | Put options by funds: $34.9M
Holders
158
Holding in Top 10
6
Calls
$16.8M
Puts
$34.9M
Top Buyers
| 1 | +$46.1M | |
| 2 | +$43.1M | |
| 3 | +$31.1M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$25.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16.3M |
Top Sellers
| 1 | -$10.7B | |
| 2 | -$91.5M | |
| 3 | -$28.6M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$19.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.5M |